Subtype-selective Modulator therapy(Kaerus Bioscience)

N/A

Report date: 2024/07/30 10:23:41
NME

Base Information

Drug NameSubtype-selective Modulator therapy(Kaerus Bioscience)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKCNQ (Kv7) potassium channel modulators
TargetsKCNQ (Kv7) potassium channel
Therapy Area/IndicationsGenetic Diseases, Inborn
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKaerus Bioscience Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKaerus Bioscience Ltd
Inactive CompaniesN/A
Active IndicationsGenetic Diseases, Inborn
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A